Clinical and genetic spectrum of a Chinese cohort with SCN4A gene mutations

[1]  Lei Zhou,et al.  Electromyographic Features in a Chinese Cohort With Hereditary Skeletal Muscle Channelopathies. , 2020, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[2]  Wei Zhang,et al.  Overlap of periodic paralysis and paramyotonia congenita caused by SCN4A gene mutations two family reports and literature review , 2019, Channels.

[3]  Young Han Lee,et al.  Lower-extremity magnetic resonance imaging in patients with hyperkalemic periodic paralysis carrying the SCN4A mutation T704M: 30-month follow-up of seven patients , 2018, Neuromuscular Disorders.

[4]  M. Hanna,et al.  Hypokalaemic periodic paralysis and myotonia in a patient with homozygous mutation p.R1451L in NaV1.4 , 2018, Scientific Reports.

[5]  L. Qi,et al.  Familial Normokalemic Periodic Paralysis Associated With Mutation in the SCN4A p.M1592V , 2018, Front. Neurol..

[6]  A. Wilde,et al.  Prevalence and mutation spectrum of skeletal muscle channelopathies in the Netherlands , 2018, Neuromuscular Disorders.

[7]  S. Cannon,et al.  Review of the Diagnosis and Treatment of Periodic Paralysis , 2017, Muscle & nerve.

[8]  M. Hanna,et al.  Predominantly myalgic phenotype caused by the c.3466G>A p.A1156T mutation in SCN4A gene , 2017, Neurology.

[9]  Xin Cheng,et al.  Clinical features and long exercise test in Chinese patients with Andersen‐Tawil syndrome , 2016, Muscle & nerve.

[10]  E. Maccagnano,et al.  Imaging alterations in skeletal muscle channelopathies: a study in 15 patients , 2015, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

[11]  C. Krarup,et al.  Loss-of-function mutations in SCN4A cause severe foetal hypokinesia or ‘classical’ congenital myopathy , 2015, Brain : a journal of neurology.

[12]  S. Cannon.  Channelopathies of skeletal muscle excitability. , 2015, Comprehensive Physiology.

[13]  Huidong Tang,et al.  Mutations of SCN4A gene cause different diseases: 2 case reports and literature review , 2015, Channels.

[14]  C. Semsarian,et al.  Genotype phenotype associations across the voltage-gated sodium channel family , 2014, Journal of Medical Genetics.

[15]  T. Yousry,et al.  Muscle MRI reveals distinct abnormalities in genetically proven non-dystrophic myotonias☆ , 2013, Neuromuscular Disorders.

[16]  S. Jaovisidha,et al.  Long-term effectiveness of acetazolamide on permanent weakness in hyperkalemic periodic paralysis , 2013, Neuromuscular Disorders.

[17]  M. Hanna,et al.  Prevalence study of genetically defined skeletal muscle channelopathies in England , 2013, Neurology.

[18]  B. Luo,et al.  Gender differences in penetrance and phenotype in hypokalemic periodic paralysis , 2013, Muscle & nerve.

[19]  M. Koltzenburg,et al.  Refined exercise testing can aid dna‐based diagnosis in muscle channelopathies , 2011, Annals of neurology.

[20]  Wei Zhang,et al.  Both hypokalaemic and normokalaemic periodic paralysis in different members of a single family with novel R1129Q mutation in SCN4A gene , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[21]  Dae-Seong Kim,et al.  Clinical Diversity of SCN4A-Mutation-Associated Skeletal Muscle Sodium Channelopathy , 2009, Journal of clinical neurology.

[22]  D. Weaver,et al.  The circadian clock protein Period 1 regulates expression of the renal epithelial sodium channel in mice. , 2009, The Journal of clinical investigation.

[23]  G. Ko,et al.  Circadian regulation of ion channels and their functions , 2009, Journal of neurochemistry.

[24]  W. Catterall,et al.  Depolarization-activated gating pore current conducted by mutant sodium channels in potassium-sensitive normokalemic periodic paralysis , 2008, Proceedings of the National Academy of Sciences.

[25]  F. Lehmann-Horn,et al.  Genotype-Phenotype correlation and therapeutic rationale in hyperkalemic periodic paralysis , 2007, Neurotherapeutics.

[26]  O. Devuyst,et al.  Gating defects of a novel Na+ channel mutant causing hypokalemic periodic paralysis. , 2006, Biochemical and biophysical research communications.

[27]  J. Willer,et al.  Cold extends electromyography distinction between ion channel mutations causing myotonia , 2006, Annals of neurology.

[28]  J. Willer,et al.  Electromyography guides toward subgroups of mutations in muscle channelopathies , 2004, Annals of neurology.

[29]  P. Ruben,et al.  Temperature‐sensitive defects in paramyotonia congenita mutants R1448C and T1313M , 2004, Muscle & nerve.

[30]  F. Lehmann-Horn,et al.  Hypokalaemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A. , 2001, Brain : a journal of neurology.

[31]  H. Lerche,et al.  Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[32]  E. Wilson,et al.  Suppression of sodium channel function in differentiating C2 muscle cells stably overexpressing rat androgen receptors , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[33]  H. Lerche,et al.  Human sodium channel myotonia: slowed channel inactivation due to substitutions for a glycine within the III‐IV linker. , 1993, The Journal of physiology.

[34]  J. Trimmer,et al.  Primary structure and functional expression of a mammalian skeletal muscle sodium channel , 1989, Neuron.

[35]  S. Cannon.  Sodium Channelopathies of Skeletal Muscle. , 2018, Handbook of experimental pharmacology.

[36]  Yingying Shi,et al.  Phenotypic variation of Val1589Met mutation in a four-generation Chinese pedigree with mild paramyotonia congenitia: case report. , 2015, International journal of clinical and experimental pathology.

[37]  S. Cannon,et al.  The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment. , 2010, Brain : a journal of neurology.